About Coastal Vista Consulting L.L.C.

Dr. Squiers is the founding Officer and managing member of Coastal Vista Consulting L.L.C. She received her B.S. degree in Science from Pennsylvania State University and her M.D. degree from Jefferson Medical College in Philadelphia, PA, in 1983. She completed surgical residency training at Beaumont Hospital in Michigan, and Transplant fellowships at University of Florida, University of Nebraska and Ohio State University. In 1990 she became an Assistant Professor of the Jefferson Medical College while at the Geisinger Medical Center, Pennsylvania. In 1994, she was an Associate Professor of Surgery and the Director of Transplantation Program at State University of New York, Syracuse. Her academic & professional career in general and transplant surgery provided a broad multidisciplinary experience ranging from intensive care to general medical follow-up of chronic diseases like end stage liver and kidney disease and diabetes, with clinical experience in oncology, infectious disease, autoimmune diseases, immunology and transplant science including end of life decisions/brain death. As Director of the Transplant Program of SUNY and its organ recovery organization, she was responsible for the management of the multi-million-dollar transplant program .

In 1998 she joined the biotech industry, initially holding multiple positions in senior management including Medical Affairs, Clinical Development and Pharmacovigilance at SangStat Medical Corporation, then, following SMC's acquisition, was VP of Clinical Development at Genzyme. Subsequently she has held positions as VP of Clinical and Regulatory at Thios Pharmaceuticals, Chief Medical Officer at Y's Therapeutics, Genani Corporation and Quark Pharmaceuticals, Inc. 

Dr. Squiers was also an independent consultant and a consultant at Pacific BioDevelopment, LLC, prior to founding and incorporating Coastal Vista Consulting in 2019. As a consultant to the biopharmaceutical industry, she has been involved in clinical development of investigational products across multiple indications including oncology, diabetes, autoimmune disease, pediatric orphan diseases, liver disease, renal disease, cardiac and metabolic disease, enzyme deficiencies, drug, biologic, generic, device, vaccine, and cell therapeutics product development, and product life cycle management.

She is board certified in general surgery and has received Regulatory Affairs Certification (RAC) , Eudravigilance and MedDRA Coder certification.  

 Experience.  Vision.  Success.